CYP19A1 and breast cancer: In vivo study reported by Ye et al. [241] in a mouse model that was injected with MCF-7aro cells, where hesperetin inhibited the activity of the aromatase enzyme (estrogen synthetase) and suppressed the proliferation of the MCF-7 breast cancer cell line.